The Arman Pirouz Iranian (APIRA) pharmaceutical company was officially registered as a private sector in 2017 to contribute to the strategic supply chain in the country by manufacturing consumer-based products and using efficient multi-phase value chains in the form of semi-finished formulations, raw materials, and finished products of medicines and supplements.
Thanks to the application of stringent standards in the pharmaceutical industry, APIRA intends to target local and global markets with a distinguished and discrete factory in terms of quality and creating value for customers.
Managers with relevant or related backgrounds in the pharmaceutical industry and invaluable years of experience in administrative positions are the crucial assets in our journey.
